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A BST R AC T   
 
Perinephric abscess is an uncommon infection in children, but it is usually caused by Escherichia 
coli, Staphylococcus aureus, Proteus mirabilis and Pseudomonas aeruginosa. Group B Streptococcus 
(GBS) is an uncommon cause of perinephric abscess or serious bacterial infections beyond the 
neonatal period. Comorbid conditions such as diabetes mellitus and immunosuppression can increase 
the risk of GBS invasive disease. We describe a 10-year-old female who presented with 1-month of 
right-sided flank pain and swelling with ultrasound showing large (>3 cm) right perinephric and 
subcutaneous abscesses. She was additionally diagnosed with new onset type 2 diabetes mellitus 
(DM) during admission. Abscess cultures obtained after placement of two percutaneous drains and 
the initiation of broad-spectrum intravenous antibiotics grew beta-hemolytic GBS. Here, we present 
to our knowledge, the first known documented case of GBS perinephric abscess in a school-aged 
child with DM. Much of the knowledge of perinephric abscess management is extrapolated from 
adults, therefore making optimal treatment in the pediatric population challenging. We propose that 
GBS be considered in the etiology of perinephric abscess in children with DM and other 
immunosuppressing conditions. In addition, percutaneous drainage of larger abscesses (>3 cm) in 
conjunction with antibiotic therapy is a reasonable management strategy. 
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Introduction  
Group B Streptococcus (GBS), known as 
Streptococcus agalactiae, is a gram-positive 
organism mostly associated with infections in 
neonates and infants. The most common 
manifestations occur as bacteremia, 
meningitis, and skin/soft tissue infections [1]. 
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Evidence of GBS infections occurring beyond 
90 days of life exists in case reports including 
a 3-year-old male with GBS retropharyngeal 
abscess and a 5-year-old female with fatal 
hemophagocytic lymphohistiocytosis due to 
GBS sepsis [2,3]. 
Perinephric and renal abscesses are uncommon 
in children but are usually associated with 
abnormal urinary tract anatomy and a history 
of repeated urinary tract infections (UTI). 
Hematogenous seeding has also been noted to 
occur. Overall incidence data ranges from 1 to 
10 cases per 10,000 hospital admissions [4-8]. 
Escherichia coli, Staphylococcus aureus, 
Proteus mirabilis, and Pseudomonas 
aeruginosa, are the most common etiologies 
for pediatric and adult patients [4-6,8]. Few 
cases of intraabdominal abscess due to GBS 
exist in the literature, and no cases of 
perinephric abscess due to GBS in a pediatric 
patient have been published to date [5,9]. 
Therefore, we present the case of GBS-induced 
perinephric abscess in a child with DM due to 
its rarity, features in diagnosis and treatment. 
 
Case report 
A 10-year-old female with asthma presented 
with a one-month history of right-sided flank 
pain and swelling. She reported subjective 
fevers, no chills, and denied dysuria and 
hematuria. Her parents endorsed polyuria, 
polydipsia, and a 45-pound weight loss over 3 
months. They denied any previous UTIs. 
On presentation, her vital signs showed a 
temperature of 38.5°C, pulse of 132 beats per 
minute, respirations of 30 per minute, and 
blood pressure of 157/83 mmHg. Her BMI of 
30.3 kg/m2 put her at the 99th percentile, 
consistent with obesity. On exam there was a 
large area of tender erythema and induration 
over the right posterolateral flank. Acanthosis 
nigricans was also noted.  
Laboratory results showed a total leukocyte 
count of 12,800 per µL with 70% neutrophils, 
5% bands, 19% lymphocytes, 6% monocytes, 
hemoglobin (Hgb) of 9.4 g/dL and a platelet 
count of 358 x103/µL. A metabolic panel 
showed glucose of 309 mg/dL with all other 
values within normal limits. Hemoglobin A1c 
(HbA1c) was 13.2%, C-reactive peptide (CRP) 
was greater than the upper limit of 270 mg/L, 
and urinalysis showed 3+ glucose, 2+ ketones, 
and negative leukocyte esterase and nitrites. 
Serum β-hydroxybutyrate was elevated to 2.20 
mmol/L. Blood culture collected before the 
initiation of broad-spectrum antibiotics was 
negative, and a midstream urine culture was 
positive for 1000 CFU of Staphylococcus 
epidermidis (deemed a contaminant). An 
abdominal ultrasound showed a heterogeneous 
area measuring 9.8x6.5x8.3 cm present in the 
subcutaneous tissue and uncertain extension 
into the right renal parenchyma. Computed 
tomography (CT) of the abdomen revealed a 
loculated right perinephric abscess measuring 
4.9x2.5x4.4 cm communicating with a larger 
loculated 7.5x4.7x11 cm collection in the 
thoracic and abdominal walls (Fig. 1).  
 
 
Fig. 1. Abdominal computed tomography 
demonstrating loculated right perinephric 
abscess measuring communicating with a 
larger loculated collection in the thoracic and 
abdominal walls.  
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The patient underwent percutaneous drain 
placement with a 12 F pigtail drain placed in 
the subcutaneous abscess and a 10 F in the 
perinephric abscess which yielded a total of 
150 cc of purulent fluid from both collections 
immediately after the procedure. Four hours 
prior to the procedure, she received 2g of 
intravenous (IV) ceftazidime and 500 mg of IV 
metronidazole with 1g of IV vancomycin 
added after abscess culture collection. Once 
abscess cultures returned positive for 4+ GBS, 
treatment was deescalated to monotherapy 
with 2 g of IV ampicillin every 6 hours. All 
antibiotic doses were calculated based on her 
weight of 80 kg. 
During hospitalization, the patient remained 
stable and received serial ultrasounds to assess 
the success of percutaneous drainage. 
Complications arose around drain output and 
leakage around the drain site and were 
managed with thrice daily flushes with tissue 
plasminogen activator and drain revision. She 
defervesced and her CRP normalized. Her 
blood glucose was managed with a sliding 
scale insulin regimen. Islet cell autoantigen 
(ICA) 512 was negative and she was therefore 
believed to have type 2 DM. She was 
transitioned to oral amoxicillin 875 mg three 
times daily after 10 days of IV therapy. After a 
17-day hospitalization, her drain output was 
consistently less than 50 cc/24 hours, and after 
training on home drain care for her family she 
was discharged to complete a total of 21 days 
of therapy from the date of drain revision. 
Outpatient follow-up was arranged for 
management of her diabetes, blood pressure, 
and drain care. 
One-week post-discharge, she was readmitted 
due to a one-day history of fever to 103°F. 
Only the subcutaneous drain remained intact, 
as the perinephric abscess drain came out at 
home 2 days prior. A CT scan revealed near-
complete resolution of the perinephric abscess 
but persistence of a subcutaneous phlegmon. 
Culture of this fluid grew Enterobacter 
cloacae, Stenotrophomonas maltophilia, and 
Pseudomonas flourescens. Ceftriaxone was 
started at 2 g every 24 hours and then switched 
to trimethoprim-sulfamethoxazole (TMP-
SMX) 160 mg twice daily based on 
susceptibilities. Her subcutaneous drain was 
removed, and after 4 days, she was discharged 
home on amoxicillin (to complete therapy for 
GBS) and TMP-SMX. She completed a total of 
4 weeks of antibiotics, and at clinic follow-up 
2 months later, she was asymptomatic and 
doing well. Follow-up renal ultrasound 
showed only residual perinephric fluid.  
 
Discussion 
Clinical presentation of perinephric abscess in 
children occurs with or without fever, dysuria, 
and abdominal pain or flank pain [4-6,10]. 
Laboratory evaluation can reveal elevated CRP 
and erythrocyte sedimentation rate, 
leukocytosis and anemia; urinalysis and renal 
function results vary depending on abscess 
communication with the collecting system of 
the kidney [4,7,10]. Imaging consists of an 
initial ultrasound to visualize the fluid; 
however, abdominal CT scan is the best 
modality for the diagnosis and determination 
of the size and extent of expansion of the 
abscess [7,10].  
A contemporary retrospective analysis of 16 
pediatric patients by Linder et al. [6] indicates 
scarce data regarding the optimal management 
of children with perinephric abscess. The 
results of their study promote conservative 
management with IV antibiotics for abscesses 
< 3 cm in diameter and make mention of an 
additional case series where lesions >3 cm 
have been managed with percutaneous and 
open surgical drainage [6,10]. Percutaneous 
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drainage is minimally invasive and appears to 
be fundamental in identifying the pathogen as 
urine and blood cultures are positive in less 
than half the cases in the adult population [9]. 
With a paucity of information on GBS disease 
in children beyond 3 months of age, our case 
suggests that greater consideration of this 
pathogen should be given in pediatric 
infections especially as worldwide incidence 
rates of GBS infections are increasing [1,11-
13]. The increase noted in adult populations 
coincides with increasing rates of 
comorbidities, especially type 2 diabetes 
[1,9,12,13]. As diabetes incidence also 
increases in children, we may expect to see a 
greater incidence of its complications 
including the infectious etiologies typically 
seen in the adult population [14,15].  
Our case is relevant because, as in a case report 
by Garcia et al. [9] which describes perinephric 
abscess in a 61-year old diabetic patient, we 
reinforce the potential association between 
GBS infections and DM. Furthermore, we also 
demonstrated successful treatment of a 
multiloculated perinephric abscess with 
percutaneous drainage as opposed to open 
surgical drainage employed in other studies 
[9,10]. Percutaneous drainage may reduce 
morbidity in patients with DM and potentially 
reduce the length of hospitalization [9]. Our 
patient was discharged home with 
percutaneous drains, and this could be a viable 
option with other pediatric patients. 
Percutaneous drainage allowed for optimal 
pathogen-directed therapy. Lastly, our case 
highlights GBS as a potential pathogen in 
perinephric abscess a may not be commonly 
seen outside of the neonatal population. It 
deserves recognition as a potential etiology of 
perinephric abscess especially in patients who 
are at increased risk with relative or absolute 
immunocompromised.  
Our case is limited in that our patient did not 
have a voiding cystourethrogram (VCUG) to 
completely rule out anatomic abnormalities of 
her urinary tract. Her serial ultrasounds were 
negative for hydronephrosis which was taken 
as objective evidence for the absence of such 
abnormalities. Further limitation identified is 
the choice of antibiotic therapy following her 
initial hospital discharge. Monotherapy with 
amoxicillin was selected based on the pure 
growth of GBS from the abscess culture.  
While gram-negative rods did not grow in the 
initial cultures, sending the patient home on 
broader therapy may have been prudent given 
the complexity of her infection. 
Pediatric patients with perinephric abscess and 
DM represent a unique population. Source 
control is key to controlling the infection and 
increasing the likelihood of successful 
antibiotic treatment. Empiric antibiotics 
should cover GBS in addition to the more 
common causes of perinephric abscess in 
children. Follow-up imaging is key to ensure 
complete resolution of perinephric abscess. 
Optimal duration of antibiotic therapy is 
unknown however continuing treatment until 
radiographic resolution has been shown to be 
successful [5,6]. Conservative management 
with antibiotics alone for lesions <3 cm and 
percutaneous or open surgical drainage for 
those >3 cm in diameter along with antibiotics 
have been shown to be successful in managing 
perinephric abscess in both adults and children 
[6,10]. Further study is required to formulate 
more concrete guidelines for the management 
of perinephric abscess in children, but its rarity 
makes this challenging. 
 
Compliance with ethical statements 
Conflicts of Interest:   None.  
Financial disclosure:   None.  
Scott et al / Pediatr Urol Case Rep. 2020; 7(5):126-130                                                                                               130 
   
 
  
Consent: Informed and written consent were 
taken from patient and her parents to publish 
this case report. 
 
ORCID iD of the author (s) 
William J. Scott / 0000-0003-1672-1825 
Aaron J. Shaw / 0000-0003-0431-6398 
Kenice D. F-Paul / 0000-0003-2180-1686 
 
References  
[1] Raabe VN, Shane AL. Group 
B Streptococcus (Streptococcus 
agalactiae). Microbiol Spectr. 2019;7(2): 
10.1128/microbiolspec.GPP3-0007-2018.  
[2]  Lo WT, Lien YH, Wang CC, et al. 
Retropharyngeal abscess caused by group B 
Streptococcus in a previously healthy child. 
Infection. 2001;29(5):289-90. 
[3] Choi YB, Yi DY. Fatal case of 
hemophagocytic lymphohistiocytosis 
associated with group B streptococcus 
sepsis: A case report. Medicine (Baltimore). 
2018;97(40):e12210-e12210. 
[4] Gardiner RA, Gwynne RA, Roberts SA. 
Perinephric abscess. BJU Int. 2011;107 
Suppl 3:20-23.   
[5] Jacobson D, Gilleland J, Cameron B, et al. 
Perinephric abscesses in the pediatric 
population: case presentation and review of 
the literature. Pediatr Nephrol. 
2014;29(5):919-25. 
[6] Linder BJ, Granberg CF. Pediatric renal 
abscesses: A contemporary series. J Pediatr 
Urol. 2016;12(2):99.e91-99.e95. 
[7] Okafor CN, Onyeaso EE. Perinephric 
Abscess. In: StatPearls. Treasure Island 
(FL): Copyright © 2020, StatPearls 
Publishing LLC.; 2020. 
[8] Rubilotta E, Balzarro M, Lacola V, et al. 
Current clinical management of renal and 
perinephric abscesses: a literature 
review. Urologia. 2014;81(3):144-47.  
[9] Peña-Garcia JI, Shaikh S, Lacasse A. 
Invasive Group B streptococcus: 
multiloculated perinephric abscesses 
treated with percutaneous drainage. J 
Community Hosp Intern Med Perspect. 
2018;8(2):76-79. 
[10] Angel C, Shu T, Green J, et al. Renal and 
peri-renal abscesses in children: proposed 
physio-pathologic mechanisms and 
treatment algorithm. Pediatr Surg Int. 
2003;19(1-2):35-39. 
[11] Bact Facts Interactive | Reports & Findings 
ABCs (Active Bacterial Core surveillance). 
https://wwwn.cdc.gov/BactFacts/index.htm
l. Published 2020. Accessed 4/10/2020. 
[12] Sendi P, Johansson L, Norrby-Teglund A. 
Invasive group B Streptococcal disease in 
non-pregnant adults : a review with 
emphasis on skin and soft-tissue infections. 
Infection. 2008;36(2):100-11. 
[13] Skoff TH, Farley MM, Petit S, et al. 
Increasing burden of invasive group B 
streptococcal disease in nonpregnant adults, 
1990-2007. Clin Infect Dis. 2009;49(1):85-
92.  
[14] Mayer-Davis EJ, Lawrence JM, Dabelea D, 
et al. Incidence Trends of Type 1 and Type 
2 Diabetes among Youths, 2002-2012. N 
Engl J Med. 2017;376(15):1419-29. 
[15] Shah AS, Nadeau KJ. The changing face of 
paediatric diabetes. Diabetologia. 
2020;63(4):683-91. 
